nodes	percent_of_prediction	percent_of_DWPC	metapath
Delavirdine—CYP3A7—Tamoxifen—pancreatic cancer	0.0456	0.0612	CbGbCtD
Delavirdine—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0456	0.0612	CbGbCtD
Delavirdine—CYP3A7—Irinotecan—pancreatic cancer	0.035	0.047	CbGbCtD
Delavirdine—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.035	0.047	CbGbCtD
Delavirdine—CYP3A5—Tamoxifen—pancreatic cancer	0.0342	0.0459	CbGbCtD
Delavirdine—CYP2C8—Tamoxifen—pancreatic cancer	0.0329	0.0441	CbGbCtD
Delavirdine—CYP1A2—Dacarbazine—pancreatic cancer	0.032	0.0429	CbGbCtD
Delavirdine—CYP3A5—Erlotinib—pancreatic cancer	0.0291	0.039	CbGbCtD
Delavirdine—CYP2C8—Erlotinib—pancreatic cancer	0.028	0.0375	CbGbCtD
Delavirdine—CYP2C19—Tamoxifen—pancreatic cancer	0.0276	0.037	CbGbCtD
Delavirdine—CYP3A5—Irinotecan—pancreatic cancer	0.0263	0.0352	CbGbCtD
Delavirdine—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.0257	0.0344	CbGbCtD
Delavirdine—CYP3A7—Docetaxel—pancreatic cancer	0.0257	0.0344	CbGbCtD
Delavirdine—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.0256	0.0343	CbGbCtD
Delavirdine—CYP3A7—Sunitinib—pancreatic cancer	0.0256	0.0343	CbGbCtD
Delavirdine—CYP1A2—Tamoxifen—pancreatic cancer	0.0255	0.0342	CbGbCtD
Delavirdine—CYP2C8—Fluorouracil—pancreatic cancer	0.0243	0.0325	CbGbCtD
Delavirdine—CYP2C9—Tamoxifen—pancreatic cancer	0.023	0.0308	CbGbCtD
Delavirdine—CYP1A2—Erlotinib—pancreatic cancer	0.0217	0.029	CbGbCtD
Delavirdine—CYP2D6—Tamoxifen—pancreatic cancer	0.021	0.0281	CbGbCtD
Delavirdine—CYP3A5—Docetaxel—pancreatic cancer	0.0193	0.0258	CbGbCtD
Delavirdine—CYP3A5—Sunitinib—pancreatic cancer	0.0192	0.0257	CbGbCtD
Delavirdine—CYP1A2—Fluorouracil—pancreatic cancer	0.0188	0.0252	CbGbCtD
Delavirdine—CYP2D6—Erlotinib—pancreatic cancer	0.0178	0.0239	CbGbCtD
Delavirdine—CYP2C9—Fluorouracil—pancreatic cancer	0.0169	0.0227	CbGbCtD
Delavirdine—CYP3A4—Tamoxifen—pancreatic cancer	0.0133	0.0179	CbGbCtD
Delavirdine—CYP3A4—Erlotinib—pancreatic cancer	0.0113	0.0152	CbGbCtD
Delavirdine—CYP3A4—Irinotecan—pancreatic cancer	0.0102	0.0137	CbGbCtD
Delavirdine—CYP2D6—Doxorubicin—pancreatic cancer	0.00881	0.0118	CbGbCtD
Delavirdine—CYP3A4—Docetaxel—pancreatic cancer	0.00751	0.0101	CbGbCtD
Delavirdine—CYP3A4—Sunitinib—pancreatic cancer	0.00748	0.01	CbGbCtD
Delavirdine—CYP3A4—Doxorubicin—pancreatic cancer	0.0056	0.00751	CbGbCtD
Delavirdine—Urticaria—Fluorouracil—pancreatic cancer	0.000126	0.000494	CcSEcCtD
Delavirdine—Headache—Sunitinib—pancreatic cancer	0.000125	0.000494	CcSEcCtD
Delavirdine—Syncope—Docetaxel—pancreatic cancer	0.000125	0.000493	CcSEcCtD
Delavirdine—Dysphagia—Doxorubicin—pancreatic cancer	0.000125	0.000492	CcSEcCtD
Delavirdine—Influenza—Doxorubicin—pancreatic cancer	0.000125	0.000492	CcSEcCtD
Delavirdine—Leukopenia—Docetaxel—pancreatic cancer	0.000125	0.000492	CcSEcCtD
Delavirdine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000125	0.000491	CcSEcCtD
Delavirdine—Eosinophilia—Doxorubicin—pancreatic cancer	0.000124	0.000488	CcSEcCtD
Delavirdine—Palpitations—Docetaxel—pancreatic cancer	0.000123	0.000486	CcSEcCtD
Delavirdine—Weight increased—Epirubicin—pancreatic cancer	0.000123	0.000484	CcSEcCtD
Delavirdine—Loss of consciousness—Docetaxel—pancreatic cancer	0.000123	0.000483	CcSEcCtD
Delavirdine—Pancreatitis—Doxorubicin—pancreatic cancer	0.000123	0.000483	CcSEcCtD
Delavirdine—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000122	0.00048	CcSEcCtD
Delavirdine—Cough—Docetaxel—pancreatic cancer	0.000122	0.00048	CcSEcCtD
Delavirdine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000122	0.000478	CcSEcCtD
Delavirdine—Pneumonia—Epirubicin—pancreatic cancer	0.000121	0.000477	CcSEcCtD
Delavirdine—Hypertension—Docetaxel—pancreatic cancer	0.000121	0.000475	CcSEcCtD
Delavirdine—Bronchitis—Doxorubicin—pancreatic cancer	0.00012	0.000474	CcSEcCtD
Delavirdine—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.00012	0.00047	CcSEcCtD
Delavirdine—Chest pain—Docetaxel—pancreatic cancer	0.000119	0.000468	CcSEcCtD
Delavirdine—Myalgia—Docetaxel—pancreatic cancer	0.000119	0.000468	CcSEcCtD
Delavirdine—Arthralgia—Docetaxel—pancreatic cancer	0.000119	0.000468	CcSEcCtD
Delavirdine—Nausea—Sunitinib—pancreatic cancer	0.000119	0.000468	CcSEcCtD
Delavirdine—Pancytopenia—Doxorubicin—pancreatic cancer	0.000119	0.000468	CcSEcCtD
Delavirdine—Asthenia—Irinotecan—pancreatic cancer	0.000118	0.000466	CcSEcCtD
Delavirdine—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000118	0.000465	CcSEcCtD
Delavirdine—Jaundice—Epirubicin—pancreatic cancer	0.000118	0.000462	CcSEcCtD
Delavirdine—Stomatitis—Epirubicin—pancreatic cancer	0.000118	0.000462	CcSEcCtD
Delavirdine—Conjunctivitis—Epirubicin—pancreatic cancer	0.000117	0.000461	CcSEcCtD
Delavirdine—Urinary tract infection—Epirubicin—pancreatic cancer	0.000117	0.000461	CcSEcCtD
Delavirdine—Neutropenia—Doxorubicin—pancreatic cancer	0.000117	0.00046	CcSEcCtD
Delavirdine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000116	0.000458	CcSEcCtD
Delavirdine—Dry mouth—Docetaxel—pancreatic cancer	0.000116	0.000458	CcSEcCtD
Delavirdine—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000116	0.000458	CcSEcCtD
Delavirdine—Asthenia—Gemcitabine—pancreatic cancer	0.000115	0.000454	CcSEcCtD
Delavirdine—Haematuria—Epirubicin—pancreatic cancer	0.000115	0.000452	CcSEcCtD
Delavirdine—Confusional state—Docetaxel—pancreatic cancer	0.000115	0.000452	CcSEcCtD
Delavirdine—Oedema—Docetaxel—pancreatic cancer	0.000114	0.000449	CcSEcCtD
Delavirdine—Weight increased—Doxorubicin—pancreatic cancer	0.000114	0.000448	CcSEcCtD
Delavirdine—Epistaxis—Epirubicin—pancreatic cancer	0.000114	0.000448	CcSEcCtD
Delavirdine—Pruritus—Gemcitabine—pancreatic cancer	0.000114	0.000447	CcSEcCtD
Delavirdine—Infection—Docetaxel—pancreatic cancer	0.000113	0.000446	CcSEcCtD
Delavirdine—Sinusitis—Epirubicin—pancreatic cancer	0.000113	0.000445	CcSEcCtD
Delavirdine—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000113	0.000444	CcSEcCtD
Delavirdine—Diarrhoea—Irinotecan—pancreatic cancer	0.000113	0.000444	CcSEcCtD
Delavirdine—Pneumonia—Doxorubicin—pancreatic cancer	0.000112	0.000442	CcSEcCtD
Delavirdine—Shock—Docetaxel—pancreatic cancer	0.000112	0.000441	CcSEcCtD
Delavirdine—Pruritus—Fluorouracil—pancreatic cancer	0.000112	0.00044	CcSEcCtD
Delavirdine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000112	0.000439	CcSEcCtD
Delavirdine—Tachycardia—Docetaxel—pancreatic cancer	0.000111	0.000438	CcSEcCtD
Delavirdine—Skin disorder—Docetaxel—pancreatic cancer	0.000111	0.000436	CcSEcCtD
Delavirdine—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000111	0.000435	CcSEcCtD
Delavirdine—Bradycardia—Epirubicin—pancreatic cancer	0.00011	0.000434	CcSEcCtD
Delavirdine—Diarrhoea—Gemcitabine—pancreatic cancer	0.00011	0.000433	CcSEcCtD
Delavirdine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000109	0.00043	CcSEcCtD
Delavirdine—Dizziness—Irinotecan—pancreatic cancer	0.000109	0.000429	CcSEcCtD
Delavirdine—Stomatitis—Doxorubicin—pancreatic cancer	0.000109	0.000428	CcSEcCtD
Delavirdine—Jaundice—Doxorubicin—pancreatic cancer	0.000109	0.000428	CcSEcCtD
Delavirdine—Anorexia—Docetaxel—pancreatic cancer	0.000109	0.000428	CcSEcCtD
Delavirdine—Rhinitis—Epirubicin—pancreatic cancer	0.000109	0.000427	CcSEcCtD
Delavirdine—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000108	0.000427	CcSEcCtD
Delavirdine—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000108	0.000427	CcSEcCtD
Delavirdine—Hepatitis—Epirubicin—pancreatic cancer	0.000108	0.000426	CcSEcCtD
Delavirdine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000108	0.000425	CcSEcCtD
Delavirdine—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000108	0.000424	CcSEcCtD
Delavirdine—Pharyngitis—Epirubicin—pancreatic cancer	0.000107	0.000423	CcSEcCtD
Delavirdine—Oedema peripheral—Epirubicin—pancreatic cancer	0.000107	0.00042	CcSEcCtD
Delavirdine—Hypotension—Docetaxel—pancreatic cancer	0.000107	0.000419	CcSEcCtD
Delavirdine—Haematuria—Doxorubicin—pancreatic cancer	0.000106	0.000419	CcSEcCtD
Delavirdine—Epistaxis—Doxorubicin—pancreatic cancer	0.000105	0.000414	CcSEcCtD
Delavirdine—Vomiting—Irinotecan—pancreatic cancer	0.000105	0.000413	CcSEcCtD
Delavirdine—Sinusitis—Doxorubicin—pancreatic cancer	0.000105	0.000412	CcSEcCtD
Delavirdine—Dizziness—Fluorouracil—pancreatic cancer	0.000104	0.000411	CcSEcCtD
Delavirdine—Rash—Irinotecan—pancreatic cancer	0.000104	0.000409	CcSEcCtD
Delavirdine—Dermatitis—Irinotecan—pancreatic cancer	0.000104	0.000409	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000104	0.000409	CcSEcCtD
Delavirdine—Headache—Irinotecan—pancreatic cancer	0.000103	0.000407	CcSEcCtD
Delavirdine—Insomnia—Docetaxel—pancreatic cancer	0.000103	0.000406	CcSEcCtD
Delavirdine—Paraesthesia—Docetaxel—pancreatic cancer	0.000102	0.000403	CcSEcCtD
Delavirdine—Erythema multiforme—Epirubicin—pancreatic cancer	0.000102	0.000403	CcSEcCtD
Delavirdine—Vomiting—Gemcitabine—pancreatic cancer	0.000102	0.000402	CcSEcCtD
Delavirdine—Bradycardia—Doxorubicin—pancreatic cancer	0.000102	0.000401	CcSEcCtD
Delavirdine—Dyspnoea—Docetaxel—pancreatic cancer	0.000102	0.0004	CcSEcCtD
Delavirdine—Somnolence—Docetaxel—pancreatic cancer	0.000101	0.000399	CcSEcCtD
Delavirdine—Rash—Gemcitabine—pancreatic cancer	0.000101	0.000399	CcSEcCtD
Delavirdine—Dermatitis—Gemcitabine—pancreatic cancer	0.000101	0.000398	CcSEcCtD
Delavirdine—Tinnitus—Epirubicin—pancreatic cancer	0.000101	0.000397	CcSEcCtD
Delavirdine—Headache—Gemcitabine—pancreatic cancer	0.000101	0.000396	CcSEcCtD
Delavirdine—Vomiting—Fluorouracil—pancreatic cancer	0.0001	0.000395	CcSEcCtD
Delavirdine—Rhinitis—Doxorubicin—pancreatic cancer	0.0001	0.000395	CcSEcCtD
Delavirdine—Dyspepsia—Docetaxel—pancreatic cancer	0.0001	0.000395	CcSEcCtD
Delavirdine—Hepatitis—Doxorubicin—pancreatic cancer	0.0001	0.000394	CcSEcCtD
Delavirdine—Hypoaesthesia—Doxorubicin—pancreatic cancer	9.97e-05	0.000392	CcSEcCtD
Delavirdine—Rash—Fluorouracil—pancreatic cancer	9.96e-05	0.000392	CcSEcCtD
Delavirdine—Dermatitis—Fluorouracil—pancreatic cancer	9.95e-05	0.000392	CcSEcCtD
Delavirdine—Pharyngitis—Doxorubicin—pancreatic cancer	9.94e-05	0.000391	CcSEcCtD
Delavirdine—Decreased appetite—Docetaxel—pancreatic cancer	9.91e-05	0.00039	CcSEcCtD
Delavirdine—Headache—Fluorouracil—pancreatic cancer	9.9e-05	0.000389	CcSEcCtD
Delavirdine—Oedema peripheral—Doxorubicin—pancreatic cancer	9.87e-05	0.000388	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	9.84e-05	0.000387	CcSEcCtD
Delavirdine—Fatigue—Docetaxel—pancreatic cancer	9.83e-05	0.000387	CcSEcCtD
Delavirdine—Nausea—Irinotecan—pancreatic cancer	9.8e-05	0.000386	CcSEcCtD
Delavirdine—Constipation—Docetaxel—pancreatic cancer	9.75e-05	0.000384	CcSEcCtD
Delavirdine—Pain—Docetaxel—pancreatic cancer	9.75e-05	0.000384	CcSEcCtD
Delavirdine—Chills—Epirubicin—pancreatic cancer	9.71e-05	0.000382	CcSEcCtD
Delavirdine—Alopecia—Epirubicin—pancreatic cancer	9.57e-05	0.000376	CcSEcCtD
Delavirdine—Nausea—Gemcitabine—pancreatic cancer	9.54e-05	0.000376	CcSEcCtD
Delavirdine—Erythema multiforme—Doxorubicin—pancreatic cancer	9.47e-05	0.000373	CcSEcCtD
Delavirdine—Erythema—Epirubicin—pancreatic cancer	9.42e-05	0.000371	CcSEcCtD
Delavirdine—Malnutrition—Epirubicin—pancreatic cancer	9.42e-05	0.000371	CcSEcCtD
Delavirdine—Feeling abnormal—Docetaxel—pancreatic cancer	9.4e-05	0.00037	CcSEcCtD
Delavirdine—Nausea—Fluorouracil—pancreatic cancer	9.38e-05	0.000369	CcSEcCtD
Delavirdine—Tinnitus—Doxorubicin—pancreatic cancer	9.34e-05	0.000367	CcSEcCtD
Delavirdine—Gastrointestinal pain—Docetaxel—pancreatic cancer	9.32e-05	0.000367	CcSEcCtD
Delavirdine—Flatulence—Epirubicin—pancreatic cancer	9.29e-05	0.000365	CcSEcCtD
Delavirdine—Tension—Epirubicin—pancreatic cancer	9.25e-05	0.000364	CcSEcCtD
Delavirdine—Dysgeusia—Epirubicin—pancreatic cancer	9.23e-05	0.000363	CcSEcCtD
Delavirdine—Nervousness—Epirubicin—pancreatic cancer	9.15e-05	0.00036	CcSEcCtD
Delavirdine—Back pain—Epirubicin—pancreatic cancer	9.12e-05	0.000359	CcSEcCtD
Delavirdine—Muscle spasms—Epirubicin—pancreatic cancer	9.06e-05	0.000356	CcSEcCtD
Delavirdine—Abdominal pain—Docetaxel—pancreatic cancer	9.01e-05	0.000355	CcSEcCtD
Delavirdine—Body temperature increased—Docetaxel—pancreatic cancer	9.01e-05	0.000355	CcSEcCtD
Delavirdine—Chills—Doxorubicin—pancreatic cancer	8.99e-05	0.000354	CcSEcCtD
Delavirdine—Vision blurred—Epirubicin—pancreatic cancer	8.88e-05	0.000349	CcSEcCtD
Delavirdine—Alopecia—Doxorubicin—pancreatic cancer	8.85e-05	0.000348	CcSEcCtD
Delavirdine—Ill-defined disorder—Epirubicin—pancreatic cancer	8.74e-05	0.000344	CcSEcCtD
Delavirdine—Erythema—Doxorubicin—pancreatic cancer	8.72e-05	0.000343	CcSEcCtD
Delavirdine—Malnutrition—Doxorubicin—pancreatic cancer	8.72e-05	0.000343	CcSEcCtD
Delavirdine—Anaemia—Epirubicin—pancreatic cancer	8.71e-05	0.000343	CcSEcCtD
Delavirdine—Agitation—Epirubicin—pancreatic cancer	8.66e-05	0.000341	CcSEcCtD
Delavirdine—Flatulence—Doxorubicin—pancreatic cancer	8.59e-05	0.000338	CcSEcCtD
Delavirdine—Tension—Doxorubicin—pancreatic cancer	8.56e-05	0.000337	CcSEcCtD
Delavirdine—Dysgeusia—Doxorubicin—pancreatic cancer	8.54e-05	0.000336	CcSEcCtD
Delavirdine—Malaise—Epirubicin—pancreatic cancer	8.5e-05	0.000334	CcSEcCtD
Delavirdine—Nervousness—Doxorubicin—pancreatic cancer	8.47e-05	0.000333	CcSEcCtD
Delavirdine—Vertigo—Epirubicin—pancreatic cancer	8.47e-05	0.000333	CcSEcCtD
Delavirdine—Syncope—Epirubicin—pancreatic cancer	8.45e-05	0.000333	CcSEcCtD
Delavirdine—Leukopenia—Epirubicin—pancreatic cancer	8.44e-05	0.000332	CcSEcCtD
Delavirdine—Back pain—Doxorubicin—pancreatic cancer	8.43e-05	0.000332	CcSEcCtD
Delavirdine—Hypersensitivity—Docetaxel—pancreatic cancer	8.4e-05	0.000331	CcSEcCtD
Delavirdine—Muscle spasms—Doxorubicin—pancreatic cancer	8.38e-05	0.00033	CcSEcCtD
Delavirdine—Palpitations—Epirubicin—pancreatic cancer	8.33e-05	0.000328	CcSEcCtD
Delavirdine—Loss of consciousness—Epirubicin—pancreatic cancer	8.28e-05	0.000326	CcSEcCtD
Delavirdine—Cough—Epirubicin—pancreatic cancer	8.22e-05	0.000324	CcSEcCtD
Delavirdine—Vision blurred—Doxorubicin—pancreatic cancer	8.22e-05	0.000323	CcSEcCtD
Delavirdine—Asthenia—Docetaxel—pancreatic cancer	8.18e-05	0.000322	CcSEcCtD
Delavirdine—Hypertension—Epirubicin—pancreatic cancer	8.14e-05	0.00032	CcSEcCtD
Delavirdine—Ill-defined disorder—Doxorubicin—pancreatic cancer	8.09e-05	0.000318	CcSEcCtD
Delavirdine—Pruritus—Docetaxel—pancreatic cancer	8.07e-05	0.000317	CcSEcCtD
Delavirdine—Anaemia—Doxorubicin—pancreatic cancer	8.06e-05	0.000317	CcSEcCtD
Delavirdine—Chest pain—Epirubicin—pancreatic cancer	8.02e-05	0.000316	CcSEcCtD
Delavirdine—Myalgia—Epirubicin—pancreatic cancer	8.02e-05	0.000316	CcSEcCtD
Delavirdine—Arthralgia—Epirubicin—pancreatic cancer	8.02e-05	0.000316	CcSEcCtD
Delavirdine—Agitation—Doxorubicin—pancreatic cancer	8.01e-05	0.000315	CcSEcCtD
Delavirdine—Anxiety—Epirubicin—pancreatic cancer	8e-05	0.000315	CcSEcCtD
Delavirdine—Discomfort—Epirubicin—pancreatic cancer	7.93e-05	0.000312	CcSEcCtD
Delavirdine—Malaise—Doxorubicin—pancreatic cancer	7.86e-05	0.000309	CcSEcCtD
Delavirdine—Dry mouth—Epirubicin—pancreatic cancer	7.85e-05	0.000309	CcSEcCtD
Delavirdine—Vertigo—Doxorubicin—pancreatic cancer	7.83e-05	0.000308	CcSEcCtD
Delavirdine—Syncope—Doxorubicin—pancreatic cancer	7.82e-05	0.000308	CcSEcCtD
Delavirdine—Leukopenia—Doxorubicin—pancreatic cancer	7.81e-05	0.000307	CcSEcCtD
Delavirdine—Diarrhoea—Docetaxel—pancreatic cancer	7.8e-05	0.000307	CcSEcCtD
Delavirdine—Confusional state—Epirubicin—pancreatic cancer	7.76e-05	0.000305	CcSEcCtD
Delavirdine—Palpitations—Doxorubicin—pancreatic cancer	7.71e-05	0.000303	CcSEcCtD
Delavirdine—Oedema—Epirubicin—pancreatic cancer	7.69e-05	0.000303	CcSEcCtD
Delavirdine—Loss of consciousness—Doxorubicin—pancreatic cancer	7.66e-05	0.000302	CcSEcCtD
Delavirdine—Infection—Epirubicin—pancreatic cancer	7.64e-05	0.000301	CcSEcCtD
Delavirdine—Cough—Doxorubicin—pancreatic cancer	7.61e-05	0.000299	CcSEcCtD
Delavirdine—Shock—Epirubicin—pancreatic cancer	7.57e-05	0.000298	CcSEcCtD
Delavirdine—Dizziness—Docetaxel—pancreatic cancer	7.54e-05	0.000297	CcSEcCtD
Delavirdine—Thrombocytopenia—Epirubicin—pancreatic cancer	7.53e-05	0.000296	CcSEcCtD
Delavirdine—Hypertension—Doxorubicin—pancreatic cancer	7.53e-05	0.000296	CcSEcCtD
Delavirdine—Tachycardia—Epirubicin—pancreatic cancer	7.51e-05	0.000295	CcSEcCtD
Delavirdine—Skin disorder—Epirubicin—pancreatic cancer	7.47e-05	0.000294	CcSEcCtD
Delavirdine—Hyperhidrosis—Epirubicin—pancreatic cancer	7.44e-05	0.000293	CcSEcCtD
Delavirdine—Chest pain—Doxorubicin—pancreatic cancer	7.42e-05	0.000292	CcSEcCtD
Delavirdine—Arthralgia—Doxorubicin—pancreatic cancer	7.42e-05	0.000292	CcSEcCtD
Delavirdine—Myalgia—Doxorubicin—pancreatic cancer	7.42e-05	0.000292	CcSEcCtD
Delavirdine—Anxiety—Doxorubicin—pancreatic cancer	7.4e-05	0.000291	CcSEcCtD
Delavirdine—Discomfort—Doxorubicin—pancreatic cancer	7.33e-05	0.000289	CcSEcCtD
Delavirdine—Anorexia—Epirubicin—pancreatic cancer	7.33e-05	0.000288	CcSEcCtD
Delavirdine—Dry mouth—Doxorubicin—pancreatic cancer	7.26e-05	0.000286	CcSEcCtD
Delavirdine—Vomiting—Docetaxel—pancreatic cancer	7.25e-05	0.000285	CcSEcCtD
Delavirdine—Rash—Docetaxel—pancreatic cancer	7.19e-05	0.000283	CcSEcCtD
Delavirdine—Hypotension—Epirubicin—pancreatic cancer	7.19e-05	0.000283	CcSEcCtD
Delavirdine—Dermatitis—Docetaxel—pancreatic cancer	7.18e-05	0.000283	CcSEcCtD
Delavirdine—Confusional state—Doxorubicin—pancreatic cancer	7.18e-05	0.000282	CcSEcCtD
Delavirdine—Headache—Docetaxel—pancreatic cancer	7.14e-05	0.000281	CcSEcCtD
Delavirdine—Oedema—Doxorubicin—pancreatic cancer	7.12e-05	0.00028	CcSEcCtD
Delavirdine—Infection—Doxorubicin—pancreatic cancer	7.07e-05	0.000278	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	7.01e-05	0.000276	CcSEcCtD
Delavirdine—Shock—Doxorubicin—pancreatic cancer	7e-05	0.000275	CcSEcCtD
Delavirdine—Thrombocytopenia—Doxorubicin—pancreatic cancer	6.97e-05	0.000274	CcSEcCtD
Delavirdine—Insomnia—Epirubicin—pancreatic cancer	6.96e-05	0.000274	CcSEcCtD
Delavirdine—Tachycardia—Doxorubicin—pancreatic cancer	6.95e-05	0.000273	CcSEcCtD
Delavirdine—Skin disorder—Doxorubicin—pancreatic cancer	6.91e-05	0.000272	CcSEcCtD
Delavirdine—Paraesthesia—Epirubicin—pancreatic cancer	6.91e-05	0.000272	CcSEcCtD
Delavirdine—Hyperhidrosis—Doxorubicin—pancreatic cancer	6.88e-05	0.000271	CcSEcCtD
Delavirdine—Dyspnoea—Epirubicin—pancreatic cancer	6.86e-05	0.00027	CcSEcCtD
Delavirdine—Somnolence—Epirubicin—pancreatic cancer	6.84e-05	0.000269	CcSEcCtD
Delavirdine—Anorexia—Doxorubicin—pancreatic cancer	6.78e-05	0.000267	CcSEcCtD
Delavirdine—Nausea—Docetaxel—pancreatic cancer	6.77e-05	0.000266	CcSEcCtD
Delavirdine—Dyspepsia—Epirubicin—pancreatic cancer	6.77e-05	0.000266	CcSEcCtD
Delavirdine—Decreased appetite—Epirubicin—pancreatic cancer	6.69e-05	0.000263	CcSEcCtD
Delavirdine—Hypotension—Doxorubicin—pancreatic cancer	6.65e-05	0.000262	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	6.64e-05	0.000261	CcSEcCtD
Delavirdine—Fatigue—Epirubicin—pancreatic cancer	6.63e-05	0.000261	CcSEcCtD
Delavirdine—Pain—Epirubicin—pancreatic cancer	6.58e-05	0.000259	CcSEcCtD
Delavirdine—Constipation—Epirubicin—pancreatic cancer	6.58e-05	0.000259	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	6.48e-05	0.000255	CcSEcCtD
Delavirdine—Insomnia—Doxorubicin—pancreatic cancer	6.44e-05	0.000253	CcSEcCtD
Delavirdine—Paraesthesia—Doxorubicin—pancreatic cancer	6.39e-05	0.000251	CcSEcCtD
Delavirdine—Dyspnoea—Doxorubicin—pancreatic cancer	6.34e-05	0.00025	CcSEcCtD
Delavirdine—Feeling abnormal—Epirubicin—pancreatic cancer	6.34e-05	0.000249	CcSEcCtD
Delavirdine—Somnolence—Doxorubicin—pancreatic cancer	6.33e-05	0.000249	CcSEcCtD
Delavirdine—Gastrointestinal pain—Epirubicin—pancreatic cancer	6.29e-05	0.000247	CcSEcCtD
Delavirdine—Dyspepsia—Doxorubicin—pancreatic cancer	6.26e-05	0.000246	CcSEcCtD
Delavirdine—Decreased appetite—Doxorubicin—pancreatic cancer	6.19e-05	0.000243	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	6.14e-05	0.000242	CcSEcCtD
Delavirdine—Fatigue—Doxorubicin—pancreatic cancer	6.14e-05	0.000241	CcSEcCtD
Delavirdine—Urticaria—Epirubicin—pancreatic cancer	6.11e-05	0.00024	CcSEcCtD
Delavirdine—Constipation—Doxorubicin—pancreatic cancer	6.09e-05	0.000239	CcSEcCtD
Delavirdine—Pain—Doxorubicin—pancreatic cancer	6.09e-05	0.000239	CcSEcCtD
Delavirdine—Abdominal pain—Epirubicin—pancreatic cancer	6.08e-05	0.000239	CcSEcCtD
Delavirdine—Body temperature increased—Epirubicin—pancreatic cancer	6.08e-05	0.000239	CcSEcCtD
Delavirdine—Feeling abnormal—Doxorubicin—pancreatic cancer	5.86e-05	0.000231	CcSEcCtD
Delavirdine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	5.82e-05	0.000229	CcSEcCtD
Delavirdine—Hypersensitivity—Epirubicin—pancreatic cancer	5.67e-05	0.000223	CcSEcCtD
Delavirdine—Urticaria—Doxorubicin—pancreatic cancer	5.65e-05	0.000222	CcSEcCtD
Delavirdine—Abdominal pain—Doxorubicin—pancreatic cancer	5.63e-05	0.000221	CcSEcCtD
Delavirdine—Body temperature increased—Doxorubicin—pancreatic cancer	5.63e-05	0.000221	CcSEcCtD
Delavirdine—Asthenia—Epirubicin—pancreatic cancer	5.52e-05	0.000217	CcSEcCtD
Delavirdine—Pruritus—Epirubicin—pancreatic cancer	5.44e-05	0.000214	CcSEcCtD
Delavirdine—Diarrhoea—Epirubicin—pancreatic cancer	5.26e-05	0.000207	CcSEcCtD
Delavirdine—Hypersensitivity—Doxorubicin—pancreatic cancer	5.24e-05	0.000206	CcSEcCtD
Delavirdine—Asthenia—Doxorubicin—pancreatic cancer	5.11e-05	0.000201	CcSEcCtD
Delavirdine—Dizziness—Epirubicin—pancreatic cancer	5.09e-05	0.0002	CcSEcCtD
Delavirdine—Pruritus—Doxorubicin—pancreatic cancer	5.03e-05	0.000198	CcSEcCtD
Delavirdine—Vomiting—Epirubicin—pancreatic cancer	4.89e-05	0.000192	CcSEcCtD
Delavirdine—Diarrhoea—Doxorubicin—pancreatic cancer	4.87e-05	0.000192	CcSEcCtD
Delavirdine—Rash—Epirubicin—pancreatic cancer	4.85e-05	0.000191	CcSEcCtD
Delavirdine—Dermatitis—Epirubicin—pancreatic cancer	4.84e-05	0.000191	CcSEcCtD
Delavirdine—Headache—Epirubicin—pancreatic cancer	4.82e-05	0.00019	CcSEcCtD
Delavirdine—Dizziness—Doxorubicin—pancreatic cancer	4.71e-05	0.000185	CcSEcCtD
Delavirdine—Nausea—Epirubicin—pancreatic cancer	4.57e-05	0.00018	CcSEcCtD
Delavirdine—Vomiting—Doxorubicin—pancreatic cancer	4.52e-05	0.000178	CcSEcCtD
Delavirdine—Rash—Doxorubicin—pancreatic cancer	4.49e-05	0.000177	CcSEcCtD
Delavirdine—Dermatitis—Doxorubicin—pancreatic cancer	4.48e-05	0.000176	CcSEcCtD
Delavirdine—Headache—Doxorubicin—pancreatic cancer	4.46e-05	0.000175	CcSEcCtD
Delavirdine—Nausea—Doxorubicin—pancreatic cancer	4.23e-05	0.000166	CcSEcCtD
